Effects of Elevating Brain Derived Neurotrophic Factor on Hippocampal Physiology

提高脑源性神经营养因子对海马生理的影响

基本信息

  • 批准号:
    7553921
  • 负责人:
  • 金额:
    $ 26.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Brain Derived Neurotrophic Factor (BDNF) causes a modest increase in transmitter release and a marked facilitation of long-term potentiation (LTP) at glutamatergic synapses in hippocampal slices. Work by the applicants indicates that it also has a profound effect on rhythms triggered by the cholinergic septo-hippocampal projections. The proposed studies will determine if up-regulation of BDNF reproduces the effects obtained with exogenous BDNF. A second goal is to test the hypothesis that BDNF's effects on LTP depend on activation of adhesion receptors belonging to the integrin family. Positive modulators of AMPA-type glutamate receptors (ampakines) will be used to increase BDNF production in cultured hippocampal slices. Physiological tests will be carried out after AMPA receptor drugs have been washed out and BDNF protein levels are greatly elevated above control. Specific Aim #1 tests the prediction that increased BDNF will be accompanied by reduced paired pulse facilitation and greater resistance to 'synaptic fatigue' during high frequency stimulation. Inhibitors of BDNF's trkB receptor will be used in this and subsequent experiments to confirm that the consequences of ampakine treatments depend on the neurotrophin. Specific Aim #2 examines post-synaptic functioning and plasticity including the NMDA components of synaptic responses and the induction / expression of LTP. This experiment is closely related to a component of Project Two. Specific Aim #3 compares cholinergically induced beta-rhythms in BDNF elevated slices with those in yoked controls (collaboration with Project 4). Recently discovered spontaneous rhythms will be used to determine if BDNF's effects are selective to cholinergic modulation. Specific Aim #4 will test if (a) the enhanced LTP caused by BDNF is blocked by integrin antagonists and (b) BDNF activates integrins. Specific Aim #5 tests the prediction that acute (6 hrs) and chronic (5 days) increases in BDNF protein content will be associated with different changes in synaptic physiology. Chronic increases in BDNF protein in Aim #5 will be induced with spaced applications of ampakines (see Project One). Together these studies will 1) provide a first description of the physiological changes that accompany pharmacologically-elevated endogenous BDNF levels, 2) explore a novel route whereby the neurotrophin could regulate plasticity, and 3) address issues that are critical to the clinical use of AMPA receptor modulators.
脑源性神经营养因子(BDNF)可引起海马脑片神经元突触递质释放的适度增加和长时程增强(LTP)的显著易化。申请人的工作表明,它对由胆碱能隔-海马投射触发的节律也有深远的影响。拟议的研究将确定BDNF的上调是否再现了外源性BDNF所获得的效果。第二个目标是检验BDNF对LTP的作用依赖于属于整合素家族的粘附受体的激活的假设。AMPA型谷氨酸受体的正调节剂(ampakines)将用于增加培养的海马切片中BDNF的产生。生理测试将在AMPA受体药物被洗出并且BDNF蛋白水平大大高于对照后进行。特定目标#1测试了以下预测:在高频刺激期间,增加的BDNF将伴随着减少的成对脉冲易化和对“突触疲劳”的更大抵抗力。BDNF的trkB受体的抑制剂将用于本实验和后续实验,以证实ampakine治疗的结果取决于神经营养因子。具体目标#2检查突触后功能和可塑性,包括突触反应的NMDA组分和LTP的诱导/表达。这个实验与项目二的一个组成部分密切相关。具体目标#3比较了BDNF升高切片中胆碱能诱导的β-节律与 控制系统(与项目4合作)。最近发现的自发节律将用于确定BDNF的作用是否对胆碱能调节具有选择性。具体目标#4将测试(a)由BDNF引起的增强的LTP是否被整联蛋白拮抗剂阻断和(B)BDNF是否激活整联蛋白。具体目标#5测试了BDNF蛋白含量的急性(6小时)和慢性(5天)增加将与突触生理学的不同变化相关的预测。目标5中BDNF蛋白的慢性增加将通过间隔应用ampakines来诱导(见项目一)。这些研究将:(1)提供 首次描述了伴随药理学升高的内源性BDNF水平的生理变化,2)探索了神经营养因子可以调节可塑性的新途径,和3)解决了AMPA受体调节剂临床应用的关键问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY S LYNCH其他文献

GARY S LYNCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY S LYNCH', 18)}}的其他基金

Epigenetic mechanisms in the medial habenula governing drug-seeking behavior
内侧缰核的表观遗传机制控制药物寻求行为
  • 批准号:
    10210374
  • 财政年份:
    2020
  • 资助金额:
    $ 26.99万
  • 项目类别:
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior
内侧缰核的表观遗传机制控制药物寻求行为
  • 批准号:
    10612113
  • 财政年份:
    2020
  • 资助金额:
    $ 26.99万
  • 项目类别:
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior
内侧缰核的表观遗传机制控制药物寻求行为
  • 批准号:
    10382355
  • 财政年份:
    2020
  • 资助金额:
    $ 26.99万
  • 项目类别:
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior
内侧缰核的表观遗传机制控制药物寻求行为
  • 批准号:
    10754682
  • 财政年份:
    2020
  • 资助金额:
    $ 26.99万
  • 项目类别:
Role of Neuron-Specific Nucleosome Remodeling in Intellectual Disability
神经元特异性核小体重塑在智力障碍中的作用
  • 批准号:
    9082570
  • 财政年份:
    2015
  • 资助金额:
    $ 26.99万
  • 项目类别:
Role of neuron-specific nucleosome remodeling in intellectual disability
神经元特异性核小体重塑在智力障碍中的作用
  • 批准号:
    9272441
  • 财政年份:
    2013
  • 资助金额:
    $ 26.99万
  • 项目类别:
Role of neuron-specific nucleosome remodeling in intellectual disability
神经元特异性核小体重塑在智力障碍中的作用
  • 批准号:
    8560955
  • 财政年份:
    2013
  • 资助金额:
    $ 26.99万
  • 项目类别:
Role of neuron-specific nucleosome remodeling in intellectual disability
神经元特异性核小体重塑在智力障碍中的作用
  • 批准号:
    8694099
  • 财政年份:
    2013
  • 资助金额:
    $ 26.99万
  • 项目类别:
Role of neuron-specific nucleosome remodeling in intellectual disability
神经元特异性核小体重塑在智力障碍中的作用
  • 批准号:
    9069518
  • 财政年份:
    2013
  • 资助金额:
    $ 26.99万
  • 项目类别:
Kinase Inhibitors against Neurodegeneration
激酶抑制剂对抗神经退行性变
  • 批准号:
    6736607
  • 财政年份:
    2004
  • 资助金额:
    $ 26.99万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 26.99万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了